| 000 | 01772 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516052014.0 | ||
| 264 | 0 | _c20120515 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1460-2083 | ||
| 024 | 7 |
_a10.1093/hmg/ddr360 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMutsaers, Chantal A | |
| 245 | 0 | 0 |
_aReversible molecular pathology of skeletal muscle in spinal muscular atrophy. _h[electronic resource] |
| 260 |
_bHuman molecular genetics _cNov 2011 |
||
| 300 |
_a4334-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Mutant Strains |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aMuscular Atrophy, Spinal _xdrug therapy |
| 650 | 0 | 4 |
_aSMN Complex Proteins _xgenetics |
| 650 | 0 | 4 |
_aSurvival of Motor Neuron 1 Protein _xgenetics |
| 650 | 0 | 4 |
_aSurvival of Motor Neuron 2 Protein _xgenetics |
| 650 | 0 | 4 | _aVorinostat |
| 700 | 1 | _aWishart, Thomas M | |
| 700 | 1 | _aLamont, Douglas J | |
| 700 | 1 | _aRiessland, Markus | |
| 700 | 1 | _aSchreml, Julia | |
| 700 | 1 | _aComley, Laura H | |
| 700 | 1 | _aMurray, Lyndsay M | |
| 700 | 1 | _aParson, Simon H | |
| 700 | 1 | _aLochmüller, Hanns | |
| 700 | 1 | _aWirth, Brunhilde | |
| 700 | 1 | _aTalbot, Kevin | |
| 700 | 1 | _aGillingwater, Thomas H | |
| 773 | 0 |
_tHuman molecular genetics _gvol. 20 _gno. 22 _gp. 4334-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/hmg/ddr360 _zAvailable from publisher's website |
| 999 |
_c21085077 _d21085077 |
||